Company type
Limited Corporation
Established
2003
Size
Small
Employees
11
Revenue
569 MDKK
Gross profit
23 MDKK
Operating Profit (EBIT)
14 MDKK
Profit for the year
31 MDKK
Equity
139 MDKK
ad

More financial key figures and analyses?

In Bisbase Premium you get more financial key figures for both companies, groups and industries plus access to exclusive industries complied by experts. You can also create your own analyses! It only takes a minute or so - and it's free!

Rank Profit for the year

Rank in industry
16/1,448
"Top 10%"
Rank in Denmark
4,638/352,565
"Top 10%"

Top management top 3

Board top 3

Steen Meldgaard Astrup 2Chairman of board
Christoph Schrader 1Boardmember
Mads Christian Olesen 18Boardmember

Legal owners top 3

66.67-89.99%Chr. Olesen A/S
5-9.99%Ignacio de Rojas

Rights certificate

Selskabet tegnes af en direktør eller et bestyrelsesmedlem eller af den samlede bestyrelse.

Company information based on CVR

NameChr. Olesen Nutrition A/S
CVR27270883
AddressJægersborg Alle 164, 2820 Gentofte
IndustryNon-specialized wholesale trade [469000]
Established30-06-2003 (21 yr)
First financial statement period30-06-2003 to 30-09-2004
Company typeLimited Corporation
Number of employees4 (man years:3)
Advertising protectionNo
AuditorPricewaterhousecoopers Statsautoriseret Revisionspartnerselskab since 01-07-2011
Financial statement period01-10 to 30-09
Bank connectionSydbank
Company capital537,500 DKK
500,000 DKK (30-06-2003 - 29-09-2022)
Articles of assoc. last30-09-2022

Member of industries

Purpose

Selskabets formål er at drive handel med og distribution af fine chemicals til pharma- og fødevareindustrien.

Financial Statement

 202320222021
Currency/unit000' DKK000' DKK000' DKK
Revenue
568,773
-2%
579,794
+54%
377,494
+22%
Gross Profit
23,253
-41%
39,331
+174%
14,343
-27%
Profit for the year
30,651
-48%
58,619
+127%
25,782
+15%
Equity
138,615
+8%
128,171
+113%
60,239
-22%
Total Assets
420,257
-14%
486,172
+89%
257,108
+29%

Mangement review summary

Management's review
Key activities Chr. Olesen Nutrition A/S is a part of the Chr. Olesen Group.Chr. Olesen Group was established in 1885 and is now represented by the 4th and 5th generation. The Company has grown to a multinational group during the 4th generation.Chr. Olesen Group is operating within international distribution of ingredients and additives for animal feed (FEED), ingredients and additives for human use (FOOD) and pharmaceutical products (PHARMA) for humans and for animals (ACTIVET) and, from 2023, also with ingredients for the technical industry – including minerals (INDUSTRIAL).Along with the trading of products (purchase and sale), the Chr. Olesen Group is highly specialised in the services required to deliver the products – ie shipping, inventory management, financing, insurance, bookkeeping and quality management.Chr. Olesen Nutrition A/S is a subsidiary within the Chr. Olesen Group. The company covers distribution of Food ingredients to Europe. The company has no direct employees, but is part of the costs in Chr. Olesen A/S. Development in the year The income statement of the Company for 2022/23 shows a profit of EUR 4,107,575, and at 30 September 2023 the balance sheet of the Company shows positive equity of EUR 18,576,161. The past year and follow-up on development expectations from last year Revenue for the year is above expected levels. The company have experienced progress in relation to expectationsManagement considers the results to be satisfactory. Capital resources The credit facilities of the Chr. Olesen Group are renegotiated every year in January/February. Credit facilities for the Chr. Olesen Group are expected to be negotiated to the same level as last year. Foreign exchange risks Significant parts of the Group’s transactions take place in foreign currencies. As an element in the Group’s business strategy, Management has determined that day-to-day foreign currency exposures should be hedged by entering into forward exchange contracts, periodical borrowing or placement of funds in foreign currencies. Moreover, currency options are also used for hedging purposes. Targets and expectations for the year ahead Chr. Olesen Group will continue the strategy of growing and consolidating all of its companies - including developing Chr. Olesen Nutrition A/S in the long-term perspective.In the coming year, same as last year, special emphasis will be placed on further upgrading of the the organisation's communication about safety (safety culture).Management expects a financial year with revenue equivalent compared to last year despite intensifying competition. Subsequent events No events materially affecting the assessment of the Annual Report have occurred after the balance sheet date.
Date of general meeting: 01-02-2024

Map